Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Gastric Cancer”

1,662 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,662 results

Early research (Phase 1)Study completedNCT03343301
What this trial is testing

Bemarituzumab (FPA144) Combined With Modified FOLFOX6 in Gastric/Gastroesophageal Cancer

Who this might be right for
Gastrointestinal CancerGastrointestinal Cancer MetastaticGastric Cancer
Five Prime Therapeutics, Inc. 12
Testing effectiveness (Phase 2)UnknownNCT01100801
What this trial is testing

Genomic-guided 'Standard-of-care' Chemotherapy for in Advanced Gastric Cancer Patients

Who this might be right for
Recurrent Gastric Cancer
National University Hospital, Singapore 90
Testing effectiveness (Phase 2)UnknownNCT02163291
What this trial is testing

Study on Neoadjuvant Chemotherapy for Advanced Gastric Cancer

Who this might be right for
Advanced Gastric Carcinoma
Peking University 30
Not applicableStudy completedNCT02951091
What this trial is testing

Biomarker-Integrated Umbrella, Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Yonsei University 400
Testing effectiveness (Phase 2)WithdrawnNCT03818997
What this trial is testing

Combination of Targeted and Immunotherapy for Advanced Biliary Tract and Esophagogastric Gastric Cancer

Who this might be right for
Esophageal CancerBiliary Tract CancerGastroEsophageal Cancer+1 more
European Organisation for Research and Treatment of Cancer - EORTC
Testing effectiveness (Phase 2)UnknownNCT02177552
What this trial is testing

Study Assessing the Effects of Chemotherapy in Advanced Esophagogastric Adenocarcinoma

Who this might be right for
Esophageal NeoplasmsStomach Neoplasms
Rigshospitalet, Denmark 98
Testing effectiveness (Phase 2)Study completedNCT01522768
What this trial is testing

Afatinib and Paclitaxel in Patients With Advanced HER2-Positive Trastuzumab-Refractory Advanced Esophagogastric Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Memorial Sloan Kettering Cancer Center 42
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06492317
What this trial is testing

RC48 Plus AK104 as First-line Treatment for HER2-overexpressing Advanced Gastric Cancer

Who this might be right for
HER2-positive Gastric Cancer
The First Affiliated Hospital of Zhengzhou University 20
Not applicableNot Yet RecruitingNCT04658589
What this trial is testing

Laparoscopic vs. Open Distal Gastrectomy After Neoadjuvant Chemotherapy

Who this might be right for
Stomach Neoplasm
Chonnam National University Hospital 238
Testing effectiveness (Phase 2)Study completedNCT00767377
What this trial is testing

Continuous Infusion of FU Combined With Epirubicin and Oxaliplatin in Patients With A/MGC

Who this might be right for
Gastric Cancer
Fudan University 163
Large-scale testing (Phase 3)Ended earlyNCT00824785
What this trial is testing

REAL3 Trial of Efficacy of EOX With/Without Panitumumab in Previously Untreated Adv OG Cancer

Who this might be right for
Oesophago-gastric Cancer
Royal Marsden NHS Foundation Trust 574
Testing effectiveness (Phase 2)UnknownNCT04367025
What this trial is testing

Efficacy and Safety of Perioperative Chemotherapy Plus PD-1 Antibody in Gastric Cancer

Who this might be right for
Gastric Cancer
Chinese PLA General Hospital 70
Early research (Phase 1)Active Not RecruitingNCT05891171
What this trial is testing

Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers

Who this might be right for
Advanced CancerAdvanced MalignanciesBladder Cancer+9 more
Arcus Biosciences, Inc. 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07266025
What this trial is testing

Adebrelimab Combined With Induction Chemotherapy or SHR-8068 for Mismatch Repair-Deficient/Microsatellite Instability-High (dMMR/MSI-H) Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma：A Randomized, Non-comparative Phase 2 Study

Who this might be right for
Gastric AdenocarcinomaGastroesophageal AdenocarcinomaMismatch Repair Deficient or MSI-High Solid Tumors+1 more
Shanghai Zhongshan Hospital 30
Not applicableUnknownNCT05442138
What this trial is testing

A Study on the Potential Benefit of Neoadjuvant Therapy for AGC Patients

Who this might be right for
Early Gastric CancerTumor Organoids
Henan Cancer Hospital 54
Large-scale testing (Phase 3)Looking for participantsNCT06784752
What this trial is testing

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

Who this might be right for
Somatostatin Receptor Positive (SSTR+)Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
Novartis Pharmaceuticals 240
Large-scale testing (Phase 3)Looking for participantsNCT04483076
What this trial is testing

Oxaliplatin Combined With S-1(SOX) Neoadjuvant Chemotherapy for Different Cycles in Patients With Gastric Cancer

Who this might be right for
Gastric CancerChemotherapy Effect
Chinese PLA General Hospital 524
Not applicableStudy completedNCT01996540
What this trial is testing

The Role of Early Systematic Best Palliative Care Versus on Request Palliative Care Consultation During Standard Oncologic Treatment for Patients With Advanced Gastric or Pancreatic Cancers: a Randomized, Controlled, Multicenter Trial.

Who this might be right for
Pancreatic NeoplasmGastric Neoplasm
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 394
Testing effectiveness (Phase 2)Study completedNCT00940225
What this trial is testing

Study of Cabozantinib (XL184) in Adults With Advanced Malignancies

Who this might be right for
Solid TumorsCancer
Exelixis 730
Not applicableStudy completedNCT04920747
What this trial is testing

Interest of the Addition of Docetaxel to Standard Treatment in First-line Advanced HER2 Positive Gastroesophageal Adenocarcinoma in Selective Patients

Who this might be right for
HER2-positive Gastric CancerMetastatic CancerDocetaxel+1 more
Centre Hospitalier Universitaire de Besancon 65
Load More Results